AN UPDATED TWO-YEAR SURVIVAL ANALYSIS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (R/R-LBCL)

被引：1
|
作者：
Diakite, I [1 ]
Lin, V. W. [2 ]
Klijn, S. [3 ]
Navale, L. [2 ]
Purdum, A. G. [2 ]
Fenwick, E. [4 ]
Botteman, M. [1 ]
van Hout, B. [5 ]
机构：
[1] Pharmerit Int, Bethesda, MD USA
[2] Kite, Santa Monica, CA USA
[3] Pharmerit Int, Rotterdam, Netherlands
[4] Pharmerit Int, Oxford, England
[5] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.050
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MS2
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [21] ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)
    Kenderian, Saad S.
    Oluwole, Olalekan O.
    McCarthy, Philip L.
    Reshef, Ran
    Shiraz, Parveen
    Ahmed, Omar
    Le Gall, John
    Nahas, Myrna
    Tang, Lily
    Neelapu, Sattva S.
    BLOOD, 2020, 136
  • [22] Primary Analysis of ZUMA7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) versus StandardofCare (SOC) Therapy in Patients (Pts) with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
    Ghobadi, Armin
    Locke, Frederick L.
    Miklos, David B.
    Jacobson, Caron A.
    Perales, Miguel-Angel
    Kersten, Marie Jose
    Oluwole, Olalekan O.
    Rapoport, Aaron P.
    McGuirk, Joseph P.
    Pagel, John M.
    Munoz, Javier
    Farooq, Umar
    van Meerten, Tom
    Reagan, Patrick M.
    Sureda, Anna
    Flinn, Ian W.
    Vandenberghe, Peter
    Song, Kevin W.
    Dickinson, Michael
    Minnema, Monique C.
    Riedell, Peter A.
    Leslie, Lori A.
    Chaganti, Sridhar
    Yang, Yin
    Filosto, Simone
    Schupp, Marco
    To, Christina
    Cheng, Paul
    Gordon, Leo I.
    Westin, Jason R.
    MOLECULAR THERAPY, 2022, 30 (04) : 519 - 519
  • [23] Long-Term Efficacy and Immune Reconstitution with Bendamustine As a Lymphodepleting Agent for Axicabtagene Ciloleucel (Axi-Cel) in Patients with Refractory or Relapsed Large B-Cell Lymphoma (LBCL)
    Bharadwaj, Sushma
    Lau, Eric
    Goyal, Anmol
    Hamilton, Mark P.
    Srinagesh, Hrishikesh
    Jensen, Alexandria
    Syal, Shriya
    Mallampet, Jayasindhu
    Latchford, Theresa
    Sahaf, Bita
    Weng, Wen-Kai
    Smith, Melody
    Maecker, Holden T.
    Frank, Matthew J.
    Miklos, David B.
    Dahiya, Saurabh
    BLOOD, 2023, 142
  • [24] Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6
    Oluwole, Olalekan O.
    Forcade, Edouard
    Munoz, Javier
    de Guibert, Sophie
    Vose, Julie M.
    Bartlett, Nancy L.
    Lin, Yi
    Deol, Abhinav
    McSweeney, Peter A.
    Goy, Andre H.
    Kersten, Marie Jose
    Jacobson, Caron A.
    Farooq, Umar
    Minnema, Monique C.
    Thieblemont, Catherine
    Timmerman, John
    Stiff, Patrick
    Avivi, Irit
    Tzachanis, Dimitrios
    Zheng, Yan
    Vardhanabhuti, Saran
    Nater, Jenny
    Shen, Rhine R.
    Miao, Harry
    Kim, Jenny
    van Meerten, Tom
    BLOOD, 2022, 140 : 10399 - 10401
  • [25] Primary overall survival (OS) analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in relapsed/refractory large B-cell lymphoma (R/R LBCL)
    Dreger, P.
    Westin, J.
    Oluwole, O.
    Kersten, M. J.
    Miklos, D.
    Perales, M. -A
    Ghobadi, A.
    Rapoport, A.
    Sureda, A.
    Jacobson, C.
    Farooq, U.
    van Meerten, T.
    Ulrickson, M.
    Elsawy, M.
    Leslie, L.
    Chaganti, S.
    Dickinson, M.
    Yang, Y.
    Schupp, M.
    To, C.
    Locke, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 271 - 272
  • [26] Long-term (5 year) overall survival in zuma-1, the pivotal study of axicabtagene ciloleucel (axi-cel) in patients with refractory large b-cell lymphoma (LBCL)
    Jacobson, C. A.
    Locke, F. L.
    Ghobadi, A.
    Miklos, D. B.
    Lekakis, L. J.
    Oluwole, O. O.
    Lin, Y.
    Hill, B. T.
    Timmerman, J. M.
    Deol, A.
    Reagan, P. M.
    Stiff, P.
    Flinn, I. W.
    Farooq, U.
    Goy, A. H.
    Munoz, J.
    Siddiqi, T.
    Shen, R. R.
    Bot, A. A.
    Dong, J.
    Singh, K.
    Spooner, C.
    Karalliyadda, R.
    Kim, J. J.
    Zheng, Y.
    Neelapu, S. S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 131 - 132
  • [27] Preliminary results of earlier steroid use with axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory large B cell lymphoma
    Topp, M. S.
    van Meerten, T.
    Wermke, M.
    Lugtenburg, P. J.
    Minnema, M. C.
    Song, K. W.
    Thieblemont, C.
    Jiang, Y.
    Plaks, V
    Kerber, A.
    Kersten, M. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 65 - 66
  • [28] Real-world outcomes of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) by race and ethnicity.
    Locke, Frederick L.
    Siddiqi, Tanya
    Jacobson, Caron Alyce
    Ghobadi, Armin
    Ahmed, Sairah
    Miklos, David Bernard
    Perales, Miguel-Angel
    Munoz, Javier
    Logan, Brent
    Hu, Zhen-Huan
    Miao, Harry H.
    Singh, Kanwarjit
    Shah, Jina
    Xu, Hairong
    Pasquini, Marcelo C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).
    Jacobson, Caron A.
    Locke, Frederick Lundry
    Hu, Zhen-Huan
    Siddiqi, Tanya
    Ahmed, Sairah
    Ghobadi, Armin
    Miklos, David Bernard
    Lin, Yi
    Perales, Miguel-Angel
    Lunning, Matthew Alexander
    Herr, Megan
    Hill, Brian T.
    Ganguly, Siddhartha
    Dong, Hua
    Nikiforow, Sarah
    Xie, Jing
    Xu, Hairong
    Hooper, Michele
    Kawashima, Jun
    Pasquini, Marcelo C.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed B-Cell Lymphoma Receiving Axicabtagene Ciloleucel (Axi-cel)
    Mian, Agrima
    Wei, Wei
    Hill, Brian T.
    Hamilton, Betty K.
    Pohlman, Brad
    Jagadeesh, Deepa
    Anwer, Faiz
    Kalaycio, Matt E.
    Dean, Robert M.
    Sobecks, Ronald M.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S44 - S45
12345